Prostate cancer is one of the most common cancers among men, with the American Cancer Society stating that one in eight men will be diagnosed with it during their lifetime. It is also the second-leading cause of cancer-related deaths in men, following lung cancer. However, most men diagnosed with prostate cancer don’t experience symptoms during the early stages, which makes early detection crucial.
The Link Between Screening and Prostate Cancer Risk
According to health experts, one of the primary reasons why the risk of prostate cancer has increased by 45% in recent years is the avoidance of regular prostate cancer screenings. Screening for prostate cancer, especially through prostate-specific antigen (PSA) testing, can detect the disease at an earlier stage, which improves the chances of successful treatment. Following the American Cancer Society’s recommendation, regular screenings are essential for men to monitor potential changes that could lead to prostate cancer.
The Importance of Regular Screening
Regular screenings can help detect the disease early, often before symptoms appear, and provide the opportunity for timely treatment. According to a study by the European Randomised Study of Screening for Prostate Cancer (ERSPC), early detection of prostate cancer can reduce the risk of death from this disease by 20%. The study, conducted over 20 years across seven European countries, found that regular screenings for prostate cancer significantly improved survival rates, especially for those who attended their scheduled screening appointments ERSPC.
Screening and Early Detection: A Game-Changer
The ERSPC study, led by scientists from the Erasmus MC Cancer Institute at the University Medical Centre in the Netherlands, included 72,460 men. The study’s results revealed that approximately one in six men missed their regular screening appointments. Those who did attend screenings had a 23% lower chance of dying from prostate cancer. These findings highlight the critical importance of regular screenings and early detection in improving survival rates.
Following lead study author Renée Leenen, M.D., Ph.D., the study suggests that men who avoid screenings may be less engaged in preventative healthcare in general, including healthy behaviors and lifestyle choices. She explains, “Men who opt out of regular screening appointments may be more likely to avoid healthcare altogether.” This contrasts with individuals who are proactive about their health and are more likely to participate in screenings.
Why Men Avoid Prostate Cancer Screenings
Dr. Leenen emphasized the need to better understand why some men avoid prostate cancer screenings. Addressing these reasons is crucial in increasing participation and improving early detection efforts. Health experts agree that implementing nationwide screenings for prostate cancer could be an essential step in reducing death rates from this disease.
Sources:
-
American Cancer Society: Overview on prostate cancer American Cancer Society
-
European Randomised Study of Screening for Prostate Cancer (ERSPC): Study results on early detection ERSPC
-
Erasmus MC Cancer Institute: Research and findings on prostate cancer screening Erasmus MC
